Furthermore, FHL2 was originally identified in the heart, and the association of FHL2 mutations with human cardiac hypertrophy reinforce both its importance in the heart and its relevance to human cardiac disease [15,16,17]. This evidence concerns the gene FHL2 and cardiac hypertrophy.